secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2025-05-22T23:59:59+00:00
Accession:  0001641172-25-012079
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MAIA Biotechnology stockholders approve increase in authorized common shares to 150M
--------------------------------------------------------------------------------

- Stockholders re-elected Class III directors Jean-Manassé Theagène and Stan V. Smith for three-year terms.
- Ratified Grant Thornton LLP as independent auditor for FY2025.
- Approved amendment to increase authorized common stock from 70M to 150M shares.
- Certificate of Amendment filed on May 22, 2025, effecting the share increase.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000164117225012079/0001641172-25-012079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000164117225012079/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-012079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer